Celgene Corporation

Sections

RSSNews (78)

1. May 8, 2013 Celgene Loses Sanctions Bid Against Teva Unit In Patent Row

   ...A Florida federal judge on Wednesday denied Celgene Corp.'s bid to sanction a Teva...

2. April 4, 2013 Celgene's $5.5M Patent Buy Ends Cancer-Therapy IP Row

   ... Celgene Corp. for $5.5 million, ending federal litigation in Delaware over the validity of the patents and...

3. March 12, 2013 FTC's Take On Drug Sales To Rivals May Cost Pharma

   ... investigation into similar allegations against Celgene Corp., is worried that drugmakers may be able to shield...

4. February 11, 2013 Celgene Cancer Drug Makes Regulatory Strides In China, US

   ...Overcoming serious safety concerns, Celgene Corp. on Monday announced that its blood cancer drug...

5. December 14, 2012 Mylan's Latest Focalin ANDA Brings Novartis IP Suit

   ...Celgene Corp. and Novartis Pharma AG has slapped Mylan Pharmaceuticals Inc. with a lawsuit in...

6. November 20, 2012 New Drugs, Deals Put Pharma Under Insider Trading Microscope

   ... executives from Sanofi-Aventis, Stryker and Celgene Corp. were among six people charged with using...

7. November 19, 2012 Ex-Celgene, Sanofi, Stryker Execs Accused Of Insider Trading

   ...Onetime Celgene Corp., Sanofi-Aventis and Stryker Corp. executives were among six people hit with...

8. September 14, 2012 Actelion Sues To Keep Tracleer Away From Apotex, Roxane

   ... bioequivalence testing. In 2008, for example, generic-drug producer Lannett Co. Inc. accused Celgene...

9. September 4, 2012 Celgene, Agios Settle $1B UPenn Cancer Research Suits

   ...Agios Pharmaceuticals Inc. and Celgene Corp. have agreed to settle two lawsuits brought by the...

10. July 24, 2012 Blackstone Pours $125M Into NantWorks Biopharmaceutical Arm

    ... estimated $3.7 billion, two years before Celgene Corp. snapped up Abraxis for $2.9 billion. Forbes has...

11. July 20, 2012 EU Regulator Backs UniQure's Glybera As First Gene Therapy

    ... latest quarter alone, according to the company. Celgene Corp.’s peripheral T-cell...

12. May 8, 2012 FDA Says Celgene's Revlimid Tied To Higher Cancer Risks

    ... Celgene Corp.'s blood cancer treatment drug Revlimid are at an increased risk of developing certain...

13. January 26, 2012 Celgene Snags Cancer Treatment Co. Avila For $350M

    ...Celgene Corp. has paid $350 million in cash to acquire Avila Therapeutics Inc., a biotechnology...

14. January 25, 2012 Celgene, Novartis Chastised Over Cancer Drug Claims

    ...The U.S. Food and Drug Administration chastised Celgene Corp. and Novartis AG in letters released...

15. December 15, 2011 Teva Unit Targets Celgene Breast Cancer Drug In IP Suit

    ...Teva Pharmaceutical Industries Ltd. unit Cephalon Inc. on Wednesday hit Celgene Corp. with a...

16. December 15, 2011 Cancer Institute Says Doctor Stole $1B In Research

    ... development deal with pharmaceutical giant Celgene Corp. The University of Pennsylvania’s...

17. December 8, 2011 Novartis, Celgene Hit Teva Again Over ADHD Drug Patents

    ...Celgene Corp. and Novartis AG recently hit Teva Pharmaceuticals USA Inc. with a fresh patent...

18. December 7, 2011 Lannett Cuts Deal With Celgene In Thalomid Antitrust Case

    ... Celgene Corp. unfairly blocked it from launching a generic version of Celgene’s thalidomide-based...

19. November 17, 2011 M&A MVP: Fried Frank's Alan Kaden

    ... recently, Kaden assisted Abraxis BioScience in its $2.9 billion sale to Celgene, Goldman Sachs Capital...

20. October 5, 2011 Web Pharmacies Sold Generics Under Celgene Marks: Suit

    ... using the names of Celgene Corp.'s cancer and blood disorder drugs to advertise and sell their...